Phytochemical Name : Rich Lady peach extract

Properties Information
PhytoCAT-ID PhytoCAT-53
Phytochemical name or plant extracts Rich Lady peach extract
PMID 19530711
Literature evidence The concentration to inhibit 50% of cell proliferation (IC(50)) was approximately 42 mg/L for this cell line compared to an IC(50) of approximately 130 and approximately 515 mg/L for the noncancerous breast cell line MCF-10A and the estrogen-dependent breast cancer cell line MCF-7, respectively.
IUPAC name NA
Phytochemicals’ class or type of plant extracts Crude phenolic extract
Source of phytochemicals or plant Extracts Prunus persica
Geographical availability China North-Central
Plant parts Fruits
Other cancers Breast cancer
Target gene or protein NA
Gene or Protein evidence NA
Target pathways NA
IC50 42 mg/L against MDA-MB-435 515 mg/L against MCF-7
Potency In general, RL extracts were more effective than BS extract in inhibiting the proliferation of the three cell lines, with the order of sensitivity being MDA-MB-435 > MCF-10A > MCF-7.
Cell line/ mice model MCF-7, MDA-MB-435, MCF-10A
Additional information  In conclusion, peaches and plums contain a mixture of phenolic compounds that preferentially inhibit the growth of the estrogen-independent MDA-MB-435 breast cancer cells over either the estrogen-dependent MCF-7 breast cancer cells or the breast epithelial MCF-10A cells. However, we confirmed that phenolic acids present in F(1): chlorogenic and neo-chlorogenic acids have potential as chemopreventive dietary compounds because of the relatively high growth inhibition exerted on the estrogen-independent MDA-MB-435 breast cancer cell line and low toxicity exerted in the normal MCF-10A cells.
PubChem ID NA
Additional PMIDs NA
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:1212858-2
Safety However, we confirmed that phenolic acids present in F(1): chlorogenic and neo-chlorogenic acids have potential as chemopreventive dietary compounds because of the relatively high growth inhibition exerted on the estrogen-independent MDA-MB-435 breast cancer cell line and low toxicity exerted in the normal MCF-10A cells.